AI consulting and support services are driving healthcare’s administrative automation and clinical decision support. AI hardware, including robotics and imaging systems, underpins advances in the medical device sector, while AI platforms and specialized applications are reshaping pharmaceutical research and development (R&D). Collectively, these technologies are moving AI from pilots to scaled commercial adoption.
Report Scope
- AI adoption is accelerating across healthcare sectors.
- AI boosts efficiency in drug discovery and development.
- Regulatory progress accelerates adoption of AI imaging tools.
Reasons to Buy
- Understand how AI is being used in the healthcare sector.
- Learn about the major players in AI in healthcare, and where the future of AI in healthcare is going.
- Access valuable strategic information to enhance future decision-making and inform new product development.
Table of Contents
- Executive Summary
- Players
- Value Chain
- The Impact of AI on Healthcare
- Case Studies
- Companies
- Sector Scorecards
- Glossary
- Further Reading
- Thematic Research Methodology
- Report Authors
- About the Analyst
- Contact the Publisher
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca
- Bristol Myers Squibb
- Johnson & Johnson
- Lilly
- Novartis
- Pfizer
- Roche
- Sanofi
- GE Healthcare
- Illumina
- Medtronic
- Phillips
- Siemens Healthineers

